Vascular Medicine

  • We have a greater understanding of ‘cardiac syndrome X,’ but questions remain
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine October 2021, 88 (10) 532-533; DOI: https://doi.org/10.3949/ccjm.88b.10021

    A better understanding of angina due to ischemia and no obstructive coronary artery disease has led to recognition of coronary microvascular dysfunction in many of these patients.

  • Chest pain: The importance of serial ECGs
    Rene Jansen van Rensburg, MBChB, MD, Jason Schutte, MBChB and Thomas de Beenhouwer, MD
    Cleveland Clinic Journal of Medicine October 2021, 88 (10) 538-540; DOI: https://doi.org/10.3949/ccjm.88a.20183

    Repeat electrocardiograms in a 44-year-old man who presented with severe hypertension revealed de Winter and Wellens patterns.

  • Coronary microvascular dysfunction: Considerations for diagnosis and treatment
    Coronary microvascular dysfunction: Considerations for diagnosis and treatment
    CME article
    Benita Tjoe, MD, Lili Barsky, MD, Janet Wei, MD, Bruce Samuels, MD, Babak Azarbal, MD, C. Noel Bairey Merz, MD and Chrisandra Shufelt, MD, MS
    Cleveland Clinic Journal of Medicine October 2021, 88 (10) 561-571; DOI: https://doi.org/10.3949/ccjm.88a.20140

    A review of pathophysiology, considerations for invasive and noninvasive coronary function testing, management, and remaining knowledge gaps.

  • The initial viral infection may be only part of the story
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine September 2021, 88 (9) 476-477; DOI: https://doi.org/10.3949/ccjm.88b.09021

    We clearly see that the coronavirus elicits syndromes far afield from respiratory tissues. But a virus eliciting effects seemingly distinct from the primary infection is nothing new.

  • Leriche syndrome
    Hiroki Matsuura, MD and Hiroyuki Honda, MD, PhD
    Cleveland Clinic Journal of Medicine September 2021, 88 (9) 482-483; DOI: https://doi.org/10.3949/ccjm.88a.20179

    Physical examination revealed pallor of the toes, cold extremities, dry skin, and absence of bilateral femoral pulses. The patient also disclosed erectile dysfunction.

  • An 86-year-old man with unexplained right-sided headache and vision loss
    CME article
    Marc Ohlhausen, BS, Eden Bernstein, MD and Craig D. Nielsen, MD, FACP
    Cleveland Clinic Journal of Medicine September 2021, 88 (9) 494-501; DOI: https://doi.org/10.3949/ccjm.88a.20077

    Steroid treatment for suspected giant cell arteritis brought no improvement in vision or headache severity.

  • Stress testing and noninvasive coronary imaging: What’s the best test for my patient?
    Stress testing and noninvasive coronary imaging: What’s the best test for my patient?
    Milad Matta, MD, Serge C. Harb, MD, Paul Cremer, MD, Rory Hachamovitch, MD, MSc and Chadi Ayoub, MD, PhD, FACC, FASE, FSCCT
    Cleveland Clinic Journal of Medicine September 2021, 88 (9) 502-515; DOI: https://doi.org/10.3949/ccjm.88a.20068

    A review of current tests, what they measure, their diagnostic and prognostic value, and their limitations.

  • Can I place a peripherally inserted central catheter in my patient with chronic kidney disease?
    Nora Hilda Hernandez Garcilazo, MD, Mohamed Hassanein, MD, Tushar J. Vachharajani, MD and Evamaria Anvari, MD
    Cleveland Clinic Journal of Medicine August 2021, 88 (8) 431-433; DOI: https://doi.org/10.3949/ccjm.88a.20173

    Future need for permanent dialysis access is an important consideration.

  • How do you effectively evaluate the elderly for alcohol use disorder?
    Moronkeji Fagbemi, MD, FASAM
    Cleveland Clinic Journal of Medicine August 2021, 88 (8) 434-439; DOI: https://doi.org/10.3949/ccjm.88a.20123

    A brief review of clues to an underrecognized and underdiagnosed problem with physical as well as emotional and social consequences.

  • Antiobesity drug therapy: An individualized and comprehensive approach
    Yael Mauer, MD, MPH, Marcie Parker, PharmD, BCACP and Sangeeta R. Kashyap, MD
    Cleveland Clinic Journal of Medicine August 2021, 88 (8) 440-448; DOI: https://doi.org/10.3949/ccjm.88a.20080

    As part of a comprehensive plan, these drugs can provide lasting obesity control and additional health benefits, including decreased cardiovascular risk.

Pages